Skip to main content
. 2023 Jun 7;30(32):79437–79450. doi: 10.1007/s11356-023-27717-4

Table 3.

Association between serum levels of aldehydes and serum iron levels in the multivariate linear regression model

Exposure Non-adjusted P Model 1 P Model 2 P Model 3 P
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Iron
 Ln (propanaldehyde, ng/mL) 4.43 (1.73, 7.13) < 0.01 3.92 (1.24, 6.59) < 0.01 3.27 (0.26, 6.28) 0.03 3.25 (0.24, 6.27) 0.03
Propanaldehyde (quartiles)
 Q1 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 Q2 7.04 (− 0.11, 14.19) 0.05 6.00 (− 1.07, 13.06) 0.1 5.37 (− 2.12, 12.87) 0.16 5.32 (− 2.18, 12.82 0.16
 Q3 11.49 (4.44, 18.54) < 0.01 10.23 (3.26, 17.20) < 0.01 10.87 (3.40, 18.34) < 0.01 10.85 (3.36, 18.34 0
 Q4 12.33 (5.42, 19.24) < 0.01 10.92 (4.08, 17.77) < 0.01 9.86 (2.22, 17.50) 0.01 9.88 (2.23, 17.53 0.01
P for trend < 0.01 < 0.01 < 0.01 < 0.01
 Ln (isopentanaldehyde, ng/mL) 2.94 (− 1.85, 7.74) 0.23 1.84 (− 2.92, 6.60 0.45 − 0.48 (− 7.40, 6.44) 0.89 − 0.52 (− 7.44, 6.41 0.88
Isopentanaldehyde (quartiles)
 Q1 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 Q2 7.29 (− 0.08, 14.66 0.05 6.47 (− 0.82, 13.77 0.08 5.71 (− 2.13, 13.55) 0.15 5.72 (− 2.14, 13.58) 0.15
 Q3 6.49 (− 0.78, 13.77 0.08 4.90 (− 2.34, 12.14 0.18 4.26 (− 3.54, 12.06) 0.28 4.04 (− 3.77, 11.86) 0.31
 Q4 6.87 (− 0.15, 13.88 0.06 4.82 (− 2.15, 11.79 0.18 2.82 (− 6.48, 12.13) 0.55 2.92 (− 6.40, 12.24) 0.54
P for trend 0.1 0.31 0.55 0.56
 Ln (hexanaldehyde, ng/mL) − 0.08 (− 1.11, 0.94 0.87 0.01 (− 0.99, 1.02 0.98 0.07 (− 0.94, 1.07 0.9 0.03 (− 0.99, 1.04) 0.96
Hexanaldehyde (quartiles)
 Q1 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 Q2 8.69 (1.47, 15.92) 0.02 8.18 (1.06, 15.29) 0.02 7.59 (− 0.06, 15.23) 0.05 7.65 (− 0.01, 15.32) 0.05
 Q3 9.57 (2.46, 16.69) 0.01 9.75 (2.74, 16.75) 0.01 8.51 (1.02, 16.00) 0.03 8.62 (1.12, 16.13) 0.02
 Q4 9.89 (2.93, 16.84) 0.01 9.40 (2.55, 16.26) 0.01 10.08 (2.62, 17.53) 0.01 10.28 (2.79, 17.77) 0.01
P for trend 0.01 0.01 0.01 0.01
 Ln (heptanaldehyde, ng/mL) 5.02 (− 8.06, 18.10) 0.45 3.49 (− 9.47, 16.45) 0.6 − 2.01 (− 15.70, 11.67) 0.77 − 2.11 (− 15.81, 11.58) 0.76
Heptanaldehyde (quartiles)
 Q1 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 Q2 2.50 (− 4.69, 9.69) 0.50 2.85 (− 4.24, 9.94) 0.43 1.21 (− 6.37, 8.79) 0.75 1.00 (− 6.60, 8.59) 0.80
 Q3 3.36 (− 3.83, 10.55) 0.36 3.40 (− 3.70, 10.50) 0.35 1.28 (− 6.35, 8.92) 0.74 1.30 (− 6.33, 8.94) 0.74
 Q4 6.83 (− 0.57, 14.23) 0.07 4.59 (− 2.79, 11.97) 0.22 1.21 (− 6.72, 9.14) 0.77 1.32 (− 6.62, 9.25) 0.74
P for trend 0.07 0.23 0.78 0.74
 Ln (butyraldehyde, ng/mL) 8.03 (− 0.05, 16.10) 0.05 6.49 (− 0.87, 13.85) 0.08 7.93 (− 0.14, 16.00) 0.05 8.40 (0.97, 15.83) 0.03
Butyraldehyde (quartiles)
 Q1 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 Q2 − 0.28 (− 7.89, 7.33) 0.94 − 1.00 (− 8.51, 6.50) 0.79 0.34 (− 7.55, 8.23) 0.93 0.50 (− 7.40, 8.40) 0.90
 Q3 7.51 (0.19, 14.83) 0.04 6.20 (− 1.03, 13.44) 0.09 5.68 (− 1.97, 13.32) 0.15 5.76 (− 1.89, 13.40) 0.14
 Q4 7.38 (0.03, 14.74) 0.05 5.37 (− 1.93, 12.67) 0.15 4.19 (− 3.63, 12.00) 0.29 4.29 (− 3.55, 12.13) 0.28
P for trend 0.01 0.04 0.15 0.15
 Ln (benzaldehyde, ng/mL) 1.40 (0.02, 2.78) 0.05 1.72 (0.36, 3.09) 0.01 1.39 (− 0.00, 2.78) 0.05 1.39 (0.00, 2.78) < 0.05
Benzaldehyde (quartiles)
 Q1 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 Q2 3.97 (− 2.69, 10.62) 0.24 4.35 (− 2.19, 10.89) 0.19 1.74 (− 5.35, 8.84) 0.63 1.80 (− 5.30, 8.90) 0.62
 Q3 7.10 (0.28, 13.91) 0.04 8.18 (1.48, 14.89) 0.02 5.79 (− 1.46, 13.04) 0.12 5.66 (− 1.59, 12.92) 0.13
 Q4 12.72 (5.63, 19.82) < 0.01 14.38 (7.38, 21.37) < 0.0001 12.69 (5.10, 20.28) < 0.001 12.88 (5.28, 20.48) < 0.001
P for trend < 0.01 < 0.0001 < 0.001 < 0.001

Model 1: adjusted for age and sex. Model 2: model 1 plus race/ethnicity, family PIR, education level, serum cotinine level, BMI category, and past-year alcohol consumption. Model 3: model 2 plus diabetes and hypertension. Bold values indicate statistical significance (P < 0.05). PIR poverty income ratio, OR odds ratio, CI confidence interval